Paradigm Quick-Set Plus Is Second Medtronic Class I Recall Within A Month
This article was originally published in The Gray Sheet
Executive Summary
Medtronic MiniMed estimates 200,000 Paradigm Quick-set Plus insulin infusion sets remain in U.S. distribution following a firm-initiated, Class I recall
You may also be interested in...
Compliance Matters Should Be Exempt From Coverage Requests – Medtronic
CMS' consideration of recalls associated with Medtronic's 508 and Paradigm insulin infusion pumps is "inappropriate" in the context of deciding whether to alter national coverage criteria for insulin pump therapy, the firm contends
Compliance Matters Should Be Exempt From Coverage Requests – Medtronic
CMS' consideration of recalls associated with Medtronic's 508 and Paradigm insulin infusion pumps is "inappropriate" in the context of deciding whether to alter national coverage criteria for insulin pump therapy, the firm contends
Zeiss Visulink Reflects Rise In Device Class I Recall Notifications
Carl Zeiss Meditec's Class I voluntary recall is part of a recent uptick in FDA announcements related to the most serious type of device recalls